UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 3,024	$ 3,140
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	163	175
Amortization	1,664	1,630
Provision for (recovery of) losses on accounts receivable	2	(14)
Amortization of Right of Use Assets	10	9
Deferred income taxes	(208)	(97)
Stock-based compensation expense	41	23
Tax benefit attributable to exercise of stock options	5	3
Changes in operating assets and liabilities:
Accounts receivable and other receivables	(71)	261
Inventories	207	158
Prepaid expenses and other current assets	(109)	(12)
Accounts payable	51	(31)
Accrued expenses	754	429
Total adjustments	2,509	2,534
Net cash provided by operating activities	5,533	5,674
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(10)	(454)
Net cash used in investing activities	(10)	(454)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	89	48
Common stock purchased and retired	0	(6,426)
Payment of dividends	(1,038)	(1,042)
Net cash used in financing activities	(949)	(7,420)
Effect of exchange rate changes on cash	(131)	(974)
Net increase (decrease) in cash and cash equivalents	4,443	(3,174)
Cash at beginning of period	51,590	42,787
Cash at end of period	56,033	39,613
Cash paid during the period for income taxes	153	285
Cash paid during the period for interest	$ 0	$ 0